Workflow
灵康转债
icon
Search documents
灵康药业集团股份有限公司关于 不向下修正“灵康转债”转股价格的公告
Zheng Quan Ri Bao· 2025-12-10 07:59
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: ● 截至2025年12月9日,灵康药业集团股份有限公司(以下简称"灵康药业"或"本公司")股价已出现连 续三十个交易日中至少有十五个交易日的收盘价低于当期转股价格的85%之情形,已触发"灵康转债"的 转股价格向下修正条款。 证券代码:603669 证券简称:灵康药业 公告编号:2025-077 证券代码:113610 证券简称:灵康转债 4、因触发"灵康转债"转股价格修正条款,自2025年8月1日起,转股价格由8.00元/股修正为6.50元/股, 具体内容详见《关于向下修正"灵康转债"转股价格暨转股停复牌的公告》(公告编号:2025-054)。 二、关于不向下修正转股价格的具体内容 ● 经公司第五届董事会第四次会议审议通过,公司董事会决议本次不行使"灵康转债"的转股价格向下修 正的权利,且在未来1个月内(2025年12月10日至2026年1月9日),如再次触及可转债转股价格向下修 正条款,亦不提出向下修正方案,从2026年1月12日开始重新起算,若再次触发" ...
10日投资提示:本钢转债提议下修
集思录· 2025-12-09 13:40
Group 1 - The core viewpoint of the article is that multiple shareholders of Jiukang Bio plan to transfer a total of 5% of their shares to China National Pharmaceutical Group [1] Group 2 - The article mentions that the controlling shareholder of Zai Sheng Technology intends to transfer 6.04% of the company's shares to Zhongrong Huaxin [5] - It also notes that Jiamei Packaging is planning a change of control, leading to a suspension of its stock [5] - Additionally, Shanshi Network Technology's shareholders plan to reduce their holdings by no more than 1% of the company's shares [5]
灵康药业:关于不向下修正“灵康转债”转股价格的公告
Zheng Quan Ri Bao· 2025-12-09 12:10
证券日报网讯 12月9日晚间,灵康药业发布公告称,截至2025年12月9日,公司股价已出现连续三十个 交易日中至少有十五个交易日的收盘价低于当期转股价格的85%之情形,已触发"灵康转债"的转股价格 向下修正条款。经公司第五届董事会第四次会议审议通过,公司董事会决议本次不行使"灵康转债"的转 股价格向下修正的权利,且在未来1个月内(2025年12月10日至2026年1月9日),如再次触及可转债转 股价格向下修正条款,亦不提出向下修正方案,从2026年1月12日开始重新起算,若再次触发"灵康转 债"的转股价格向下修正条件,届时公司董事会将再次召开会议审议是否行使"灵康转债"的转股价格向 下修正权利。 (文章来源:证券日报) ...
灵康药业集团股份有限公司关于聘任2025年度审计机构的公告
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:603669 证券简称:灵康药业 公告编号:2025-074 灵康药业集团股份有限公司 关于聘任2025年度审计机构的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: ● 拟聘任的会计师事务所名称:中审亚太会计师事务所(特殊普通合伙)(以下简称"中审亚太") 组织形式:特殊普通合伙企业 注册地址:北京市海淀区复兴路47号天行建商务大厦20层2206 首席合伙人:王增明 上年度末合伙人数量93人、注册会计师数量482人、签署过证券服务业务审计报告的注册会计师人数180 余人。 最近一年经审计总收入70,397.66万元、审计业务收入68,203.21万元、证券业务收入30,108.98万元。 ● 原聘任的会计师事务所名称:中审众环会计师事务所(特殊普通合伙)(以下简称"中审众环") ● 变更会计师事务所的简要原因及前任会计师的异议情况:为保障灵康药业集团股份有限公司(以下简 称"公司")年度审计工作的顺利推进,综合考虑公司的业务情况和实际需求, ...
灵康药业:关于“灵康转债”预计满足转股价格修正条件的提示性公告
Zheng Quan Ri Bao· 2025-12-02 14:11
证券日报网讯 12月2日晚间,灵康药业发布公告称,公司股票自2025年11月19日至2025年12月2日已有 10个交易日的收盘价低于当期转股价格的85%(5.53元/股),存在触发《募集说明书》中规定的转股价 格向下修正条件的可能性。若触发条件,公司将于触发条件当日召开董事会审议决定是否修正转股价 格,并及时履行信息披露义务。 (文章来源:证券日报) ...
灵康药业集团股份有限公司关于变更注册资本、取消监事会并修订《公司章程》的公告
Group 1 - The company announced changes to its registered capital, cancellation of the supervisory board, and amendments to its articles of association [1][3][21] - The company issued 5.25 million convertible bonds with a total value of 525 million yuan, which can be converted into A-shares starting from June 7, 2021 [1][2] - As of December 31, 2024, a total of 139,000 yuan of convertible bonds have been converted into 16,623 shares, increasing the total share capital from 721,227,382 shares to 721,244,005 shares [2] Group 2 - The supervisory board will be abolished, and its powers will be transferred to the audit committee of the board of directors, in accordance with relevant laws and regulations [3][21] - The amendments to the articles of association require approval from the shareholders' meeting, and the management is authorized to handle related business registration changes [4][21] Group 3 - The company held its fourth board meeting on September 22, 2025, where it approved the nomination of candidates for the fifth board of directors [8][33] - The fifth board will consist of 7 directors, including 3 non-independent directors, 3 independent directors, and 1 employee representative [33][34] - The company plans to hold a second extraordinary shareholders' meeting on October 10, 2025, to vote on the board nominations and other matters [47][50] Group 4 - The company aims to revise its governance structure to better protect the rights of investors, especially minority shareholders, and promote sustainable development [25][69] - The revised governance documents include rules for external investment management, shareholder meetings, independent director work, related party transactions, and fundraising management [69][70]
新股发行及今日交易提示-20250801
New Stock Issuance - Guangdong JianKe issued new shares at a price of 6.56 on August 1, 2025[1] - ShenKe Co., Ltd. has a tender offer period from July 29 to August 27, 2025[1] - ST Kelly's tender offer period is from July 17 to August 15, 2025[1] Market Alerts - ST Zitian reported significant abnormal fluctuations on July 21, 2025[1] - ST Suwu experienced abnormal fluctuations on July 30, 2025[1] - ST Xizang Tianlu reported significant abnormal fluctuations on August 1, 2025[1] Other Notable Announcements - Huaneng Electric's announcement was made on August 1, 2025, regarding its stock code 603063[1] - ST Sai Long's announcement was made on August 1, 2025, with stock code 002898[1] - ST Green Kang's announcement was made on July 31, 2025, with stock code 002868[1]
灵康药业集团股份有限公司2025年第一次临时股东大会决议公告
Group 1 - The first extraordinary general meeting of shareholders for 2025 was held on July 30, 2025, in Hangzhou, Zhejiang Province [2][3] - The meeting was legally convened and presided over by the company's chairman, Tao Lingping, with the presence of legal counsel from Shanghai Dongfang Huayin Law Firm [2][6] - All resolutions presented at the meeting were passed with more than two-thirds of the voting rights held by attending shareholders [5][6] Group 2 - The company announced a downward adjustment of the conversion price for "Lingkang Convertible Bonds" from 8.00 yuan/share to 6.50 yuan/share, effective from August 1, 2025 [9][15] - The adjustment was triggered as the company's stock price had been below 85% of the current conversion price for at least 15 trading days within a 30-day period [11][14] - The average trading price of the company's stock over the 20 trading days prior to the meeting was 5.91 yuan/share, and the price on the previous trading day was 6.40 yuan/share [14]
灵康药业: 关于向下修正“灵康转债”转股价格暨转股停复牌的公告
Zheng Quan Zhi Xing· 2025-07-30 16:24
Core Viewpoint - The company has announced a downward adjustment of the conversion price for its convertible bonds, "Lingkang Convertible Bonds," from 8.00 CNY to 6.50 CNY per share, effective from August 1, 2025, due to the stock price being below the current conversion price for a significant period [1][5][6] Summary by Sections 1. Securities Suspension and Resumption - The company's securities will be suspended from conversion starting July 31, 2025, and will resume on August 1, 2025 [1][6] 2. Basic Information on Convertible Bonds - The company issued 5.25 million convertible bonds on December 1, 2020, with a total value of 525 million CNY and a maturity of 6 years [1][2] 3. Adjustment of Conversion Price - The initial conversion price was set at 8.81 CNY per share, later adjusted to 8.00 CNY per share. The latest adjustment reduces it to 6.50 CNY per share [2][5] 4. Triggering Conditions for Price Adjustment - The adjustment was triggered as the company's stock price was below 85% of the current conversion price for at least 15 out of 30 consecutive trading days [5] 5. Approval Process for Price Adjustment - The board of directors approved the price adjustment on July 14, 2025, and a special resolution was passed at the shareholders' meeting on July 30, 2025, authorizing the board to implement the adjustment [5][6]
31日投资提示:灵康转债下修到底
集思录· 2025-07-30 12:45
Group 1 - The core viewpoint of the article discusses recent developments in the Chinese stock market, particularly focusing on new stock listings and convertible bonds [1] - The new stock "Youli Intelligent" on the Beijing Stock Exchange has a threshold of 6.47 million [1] - The "Lincang Convertible Bond" is undergoing a down adjustment [1] - The "Gansu Energy Chemical" has resumed production at its Wangjiashan Coal Mine, well number one [1] - The "Aofei Convertible Bond" will not be forcibly redeemed [1] - "Dongjie Intelligent" is undergoing changes in its controlling shareholder's upper-level equity structure, which may lead to a change in the actual controller [1] - The "Xianle Convertible Bond," "Shengxun Convertible Bond," and "Jingrui Convertible Bond 2" will not undergo down adjustments [1] - "Dingjia Precision" has been listed as a new stock on the Beijing Stock Exchange [1]